Stocks and Investing Stocks and Investing
Tue, November 3, 2020
Mon, November 2, 2020

Eun Yang Downgraded (BPMC) to Hold and Held Target at $96 on, Nov 2nd, 2020


Published on 2024-10-27 14:36:18 - WOPRAI, Eun Yang
  Print publication without navigation


Eun Yang of Jefferies, Downgraded "Blueprint Medicines Corporation" (BPMC) to Hold and Held Target at $96 on, Nov 2nd, 2020.

Eun has made no other calls on BPMC in the last 4 months.



There are 5 other peers that have a rating on BPMC. Out of the 5 peers that are also analyzing BPMC, 1 agrees with Eun's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Downgraded from Buy to Hold on, Friday, October 30th, 2020


These are the ratings of the 4 analyists that currently disagree with Eun


  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $120 on, Thursday, October 29th, 2020
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $122 on, Friday, October 16th, 2020
  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Increased Target to $100 on, Tuesday, October 13th, 2020
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $110 on, Wednesday, July 15th, 2020
Contributing Sources